This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Raymond Pollack, MB, FRCS
University of Illinois at Chicago

JAMA. 1997;277(17):1354.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—The case report by Dr Loh et al¹ of a donorderived prostate cancer in a heart transplant recipient and the accompanying Editorial² are interesting additions to the literature on this subject. Fortunately, this is a rare occurrence following transplantation, but it may also include the transmission not only of malignant neoplasms, but potentially morbid and sometimes lethal infectious agents (ie, hepatitis viruses, human immunodeficiency virus [HIV], and cytomegaloviruses).³ Careful predonation evaluation by organ bank personnel, including a detailed social and medical history, thorough physical examination, and a battery of biochemical and serological tests, serves to eliminate those organ donors who might transmit disease.⁴ Thereafter, a proper intraoperative assessment to detect occult disease states must be made in a collaborative way by procurement surgeons to further mitigate the transplantation of poor-quality organs or the transmission of disease.

Thus, the article by Loh et al certainly does not . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?